Sign up for free insights newsletter
30

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A

301408SHE

Need professional-grade analysis? Visit stockanalysis.com

CN¥20.21
-1.85%
End of day
Market Cap

$8.10B

P/E Ratio

44.02

Employees

7,930

Dividend Yield

0.49%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino24.60-0.752.772.294.96
Calmar57.12-0.893.151.989.58
Sharpe9.13-0.421.541.252.10
Omega7.241.930.941.341.321.72
Martin-1.335.774.753.57
Ulcer1.456.0022.5224.1218.4117.97

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) Price Performance

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) trades on SHE in CNY. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at CNY20.21, down 1.85% from the previous close.

Over the past year, 301408 has traded between a low of CNY10.65 and a high of CNY29.76. The stock has gained 88.5% over this period. It is currently 32.1% below its 52-week high.

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A has a market capitalization of $8.10B, with a price-to-earnings ratio of 44.02 and a dividend yield of 0.49%.

About Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A

Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products. Anhui Huaren Health Pharmaceutical Co., Ltd. was founded in 2001 and is based in Hefei, China.

Compare Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
SHE
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$5.15B
EBITDA
$355.60M
Profit Margin
3.62%
EPS (TTM)
0.46
Book Value
5.24

Technical Indicators

52 Week High
CN¥29.76
52 Week Low
CN¥10.55
50 Day MA
CN¥18.86
200 Day MA
CN¥16.70
Beta
0.65

Valuation

Trailing P/E
44.02
Forward P/E
N/A
Price/Sales
1.57
Price/Book
3.93
Enterprise Value
$8.78B